The Transcatheter Embolization and Occlusion Devices market is expected to be around US$ 6 Billion by 2028; Growing at a CAGR of more than 7.5% in the given forecast period.
Transcatheter embolization and occlusion (TEO) is a minimally invasive (MI) procedure performed in interventional radiology wherein an artificial embolus is placed or inserted through a fine catheter within the vessel to obstruct the blood flow towards tumour or specific area of the body. Coils are permanent embolic agents which are available a spread of shapes and sizes and are coated with chemotherapeutic drugs that block the blood supply also as induce cytotoxicity to attack the tumour.
Particulate agents like polyvinyl alcohol (PVA) and gelatine-impregnated acrylic polymer spheres are suspended in liquid and injected into the bloodstream to dam small blood vessels. This procedure is employed to stop abnormal bleeding, eliminate abnormal connections between arteries and veins, and to treat the aneurysm. Few of the main factors driving the market development are rising burden of targeted diseases, technological advances within the devices with enhanced efficiency, changing shift from clipping to coiling, rising preference for minimally invasive surgeries (MISs), and increasing adoption of TEO devices. Venous malformations are the foremost common of all vascular anomalies.
The global Transcatheter Embolization and Occlusion Devices market is segregated on the basis of Product as Coiled Devices and Non-Coiled Devices. Based on Indication the global Transcatheter Embolization and Occlusion Devices market is segmented in Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others. Based on End Users the global Transcatheter Embolization and Occlusion Devices market is segmented in Hospitals and Clinics, Ambulatory Surgery Centers (ASCs), and Others.
The global Transcatheter Embolization and Occlusion Devices market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Transcatheter Embolization and Occlusion Devices market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, Pfizer Inc., Cardinal Health, DePuy Synthes, Cook Medical, Sirtex Medical Limited, BTG plc, and others are among the major players in the global Transcatheter Embolization and Occlusion Devices market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Transcatheter Embolization and Occlusion Devices Market has been segmented as below:
Transcatheter Embolization and Occlusion Devices Market, By Product
Transcatheter Embolization and Occlusion Devices Market, By Indication
Transcatheter Embolization and Occlusion Devices Market, By End Users
Transcatheter Embolization and Occlusion Devices Market, By Region
Transcatheter Embolization and Occlusion Devices Market, By Company
The report covers:
Report Scope:
The global Transcatheter Embolization and Occlusion Devices market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Transcatheter Embolization and Occlusion Devices market share. Major industry players with significant revenue share include Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, Pfizer Inc., Cardinal Health, DePuy Synthes, Cook Medical, Sirtex Medical Limited, BTG plc, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
OTC Braces and Supports Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Transcatheter Embolization and Occlusion Devices Market, By Product
5.1 Introduction
5.2 Coiled Devices
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Non-Coiled Devices
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Transcatheter Embolization and Occlusion Devices Market, By Indication
6.1 Introduction
6.2 Peripheral Vascular Disease
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Oncology
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Neurology
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Urology
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Others
6.6.1 Market Overview
6.6.2 Market Size and Forecast
7. Transcatheter Embolization and Occlusion Devices Market, By End Users
7.1 Introduction
7.2 Hospitals and Clinics
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Ambulatory Surgery Centers (ASCs)
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Others
7.4.1 Market Overview
7.4.2 Market Size and Forecast
8. Transcatheter Embolization and Occlusion Devices Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Transcatheter Embolization and Occlusion Devices, By Product
8.2.2 North America Transcatheter Embolization and Occlusion Devices, By Indication
8.2.3 North America Transcatheter Embolization and Occlusion Devices, By End Users
8.3 Europe
8.3.1 Europe Transcatheter Embolization and Occlusion Devices, By Product
8.3.2 Europe Transcatheter Embolization and Occlusion Devices, By Indication
8.3.3 Europe Transcatheter Embolization and Occlusion Devices, By End Users
8.4 Asia-Pacific
8.4.1 Asia-Pacific Transcatheter Embolization and Occlusion Devices, By Product
8.4.2 Asia-Pacific Transcatheter Embolization and Occlusion Devices, By Indication
8.4.3 Asia-Pacific Transcatheter Embolization and Occlusion Devices, By End Users
8.5 Rest of the World
8.5.1 Rest of the World Transcatheter Embolization and Occlusion Devices, By Product
8.5.2 Rest of the World Transcatheter Embolization and Occlusion Devices, By Indication
8.5.3 Rest of the World Transcatheter Embolization and Occlusion Devices, By End Users
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
10.1 Medtronic plc
10.2 Stryker Corporation
10.3 Terumo Corporation
10.4 Boston Scientific Corporation
10.5 Pfizer Inc.
10.6 Cardinal Health
10.7 DePuy Synthes
10.8 Cook Medical
10.9 Sirtex Medical Limited
10.10 BTG plc
10.11 Penumbra, Inc.
10.12 Edwards Lifesciences Corporation
10.13 Merit Medical Systems
10.14 Johnson & Johnson Services, Inc.
10.15 Abbott Laboratories.
The Transcatheter Embolization and Occlusion Devices Market has been segmented as below:
Transcatheter Embolization and Occlusion Devices Market, By Product
Transcatheter Embolization and Occlusion Devices Market, By Indication
Transcatheter Embolization and Occlusion Devices Market, By End Users
Transcatheter Embolization and Occlusion Devices Market, By Region
Transcatheter Embolization and Occlusion Devices Market, By Company
